Titlebook: Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag; Proceedings of the N Joel Morganroth,

杀人

0166-9842 issues. The benefit versus risk data on currently available thrombolytic agents was reviewed and the potential roles for adjunctive agents addressed. Overall s978-1-4612-8888-6978-1-4613-1605-3Series ISSN 0166-9842

偏狂症

H. P. K. Agersborg,J. Lattsonal Development. is an essential resource for researchers, clinicians/professionals, and graduate students in child and school psychology, social work, public health, child and adolescent psychiatry, pediatric978-3-030-17334-0978-3-030-17332-6